Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genomic Analysis Platform Offers Insights into Health, Disease

By Labmedica staff writers
Posted on 14 May 2008
An ultra-high throughput genomic analysis system using new technology for DNA sequencing and genomic analysis has enabled scientists to adopt new approaches for studying the genetic basis of health and disease.

The new platform, the SOLiD system is an end-to-end genomic analysis solution utilizing a proprietary technology called stepwise ligation, which generates high quality data for applications including whole genome sequencing, chromatin immunoprecipitation (ChIP), microbial sequencing, digital karyotyping, medical sequencing, genotyping, gene expression, and small RNA discovery.

Applied Biosystems (Warrington, UK) has developed significant new enhancements to the SOLiD system platform, including upgrades to software and chemistry that double throughput, simplify workflows, and decrease system run times.

With the new upgrades, the SOLiD system can consistently generate more than six billion bases of sequence data per run, maintaining the system as the highest throughput genomic analysis system available today. More...
It can also generate up to 240 million sequence tags per run, which is expected to reduce the cost of conducting sequencing-based gene expression applications further.

Scientists at the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard (Cambridge, MA, USA) are using two SOLiD systems for large-scale discovery of genetic variation in human genome samples, as part of the Broad Institute's contribution to the 1000 Genomes Project, a worldwide effort to create the most detailed and medically useful picture of human genetic variation to date. The scientists generated more than 50 billion bases of DNA sequence over just six weeks.

At Columbia University Medical Center (CUMC; New York, NY, USA), scientists have been using the SOLiD system for a novel approach to study whole-genome methylation profiles in a panel of breast cancer tumors, benefiting from the mate-pair analysis capabilities of the system to map the methylation state of all regions of the genome.

The institutes presented their preliminary findings at the Cold Spring Harbor Laboratory's Biology of Genomes meeting in New York (USA) from May 6-10, 2008.


Related Links:
Applied Biosystems
Broad Institute of MIT and Harvard
Columbia University Medical Center

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.